Vice President, Investor Relations
Ms. Carroll has served as our Vice President of Investor Relations since December 2022. Prior to joining Telesis Bio, Ms. Carroll served as Director, Global Public Relations at Illumina (NASDAQ: ILMN) for four years, and as its Director of Population Genomics until 2021. During this time of extraordinary company growth from $2.4B to $4.5B+, Jen led the media relations team across the breadth of the business. In this role, she crafted and delivered strategic, executive communications programs on behalf of multiple C-suite members. Jen served in a similar role as Director, Corporate Communications at PacBio (NASDAQ: PACB) in 2021. Throughout her 25-year career, Jen has built and delivered world-class investor relations and tactical communications strategies that ultimately help drive growth, achieve business objectives and milestones. Jen holds a degree in Communications and French Studies from Saint Mary’s College in Notre Dame, Indiana.